Literature DB >> 23180812

Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia.

Kwanghyun Sohn1, Adam R Wende, E Dale Abel, Alonso P Moreno, Frank B Sachse, Bonnie B Punske.   

Abstract

Insulin resistance, which characterizes type 2 diabetes, is associated with reduced translocation of glucose transporter 4 (GLUT4) to the plasma membrane following insulin stimulation, and diabetic patients with insulin resistance show a higher incidence of ischaemia, arrhythmias and sudden cardiac death. The aim of this study was to examine whether GLUT4 deficiency leads to more severe alterations in cardiac electrical activity during cardiac stress due to hypoxia. To fulfil this aim, we compared cardiac electrical activity from cardiac-selective GLUT4-ablated (G4H-/-) mouse hearts and corresponding control (CTL) littermates. A custom-made cylindrical 'cage' electrode array measured potentials (Ves) from the epicardium of isolated, perfused mouse hearts. The normalized average of the maximal downstroke of Ves ( (|d Ves/dt(min)|na), which we previously introduced as an index of electrical activity in normal, ischaemic and hypoxic hearts, was used to assess the effects of GLUT4 deficiency on electrical activity. The |d Ves/dt(min)|na of G4H −/− and CTL hearts decreased by 75 and 47%, respectively (P < 0.05), 30 min after the onset of hypoxia. Administration of insulin attenuated decreases in values of |d Ves/dt(min)|na in G4H −/− hearts as well as in CTL hearts, during hypoxia. In general, however, G4H −/− hearts showed a severe alteration of the propagation sequence and a prolonged total activation time. Results of this study demonstrate that reduced glucose availability associated with insulin resistance and a reduction in GLUT4-mediated glucose transport impairs electrical activity during hypoxia, and may contribute to cardiac vulnerability to arrhythmias in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180812      PMCID: PMC6599691          DOI: 10.1113/expphysiol.2012.070235

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  70 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

Review 2.  Regulated transport of the glucose transporter GLUT4.

Authors:  Nia J Bryant; Roland Govers; David E James
Journal:  Nat Rev Mol Cell Biol       Date:  2002-04       Impact factor: 94.444

3.  Voltage-sensitive dye mapping in Langendorff-perfused rat hearts.

Authors:  A Nygren; C Kondo; R B Clark; W R Giles
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-11-07       Impact factor: 4.733

Review 4.  Pyruvate: metabolic protector of cardiac performance.

Authors:  R T Mallet
Journal:  Proc Soc Exp Biol Med       Date:  2000-02

5.  Diabetes as a risk factor for sudden death.

Authors:  B Balkau; X Jouven; P Ducimetière; E Eschwège
Journal:  Lancet       Date:  1999-12-04       Impact factor: 79.321

6.  Responses of GLUT4-deficient hearts to ischemia underscore the importance of glycolysis.

Authors:  R Tian; E D Abel
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

7.  Effects of lactate on intracellular pH and hypercontracture during simulated ischemia and reperfusion in cardiac ventricular myocytes of the guinea pig.

Authors:  T Tokuno; M Watanabe; Y Imaizumi
Journal:  Jpn J Pharmacol       Date:  1999-08

8.  Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.

Authors:  R R Russell; R Bergeron; G I Shulman; L H Young
Journal:  Am J Physiol       Date:  1999-08

9.  Insulin stimulates the L-type Ca2+ current in rat cardiac myocytes.

Authors:  F Aulbach; A Simm; S Maier; H Langenfeld; U Walter; U Kersting; M Kirstein
Journal:  Cardiovasc Res       Date:  1999-04       Impact factor: 10.787

10.  Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart.

Authors:  E D Abel; H C Kaulbach; R Tian; J C Hopkins; J Duffy; T Doetschman; T Minnemann; M E Boers; E Hadro; C Oberste-Berghaus; W Quist; B B Lowell; J S Ingwall; B B Kahn
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

View more
  5 in total

Review 1.  Plant-derived glucose transport inhibitors with potential antitumor activity.

Authors:  Pratik Shriwas; Xiaozhuo Chen; A Douglas Kinghorn; Yulin Ren
Journal:  Phytother Res       Date:  2019-12-10       Impact factor: 5.878

2.  Cardiac Depression in Pigs after Multiple Trauma - Characterization of Posttraumatic Structural and Functional Alterations.

Authors:  M Kalbitz; S Schwarz; B Weber; B Bosch; J Pressmar; F M Hoenes; C K Braun; K Horst; T P Simon; R Pfeifer; P Störmann; H Hummler; F Gebhard; H C Pape; M Huber-Lang; F Hildebrand
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

3.  Inhibition of sarcolemmal FAT/CD36 by sulfo-N-succinimidyl oleate rapidly corrects metabolism and restores function in the diabetic heart following hypoxia/reoxygenation.

Authors:  Latt S Mansor; Maria da Luz Sousa Fialho; Georgina Yea; Will A Coumans; James A West; Matthew Kerr; Carolyn A Carr; Joost J F P Luiken; Jan F C Glatz; Rhys D Evans; Julian L Griffin; Damian J Tyler; Kieran Clarke; Lisa C Heather
Journal:  Cardiovasc Res       Date:  2017-06-01       Impact factor: 10.787

Review 4.  Trauma, a Matter of the Heart-Molecular Mechanism of Post-Traumatic Cardiac Dysfunction.

Authors:  Birte Weber; Ina Lackner; Florian Gebhard; Theodore Miclau; Miriam Kalbitz
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 5.  New Molecular Insights of Insulin in Diabetic Cardiomyopathy.

Authors:  Francisco Westermeier; Jaime A Riquelme; Mario Pavez; Valeria Garrido; Ariel Díaz; Hugo E Verdejo; Pablo F Castro; Lorena García; Sergio Lavandero
Journal:  Front Physiol       Date:  2016-04-12       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.